Back to Search
Start Over
LONG-TERM EFFICACY OF ABROCITINIB AS MONOTHERAPY OVER 96 WEEKS IN THE JADE CLINICAL PROGRAM
- Source :
- Annals of Allergy, Asthma & Immunology; November 2024, Vol. 133 Issue: 6, Number 6 Supplement 1 pS100-S100, 1p
- Publication Year :
- 2024
-
Abstract
- The efficacy of abrocitinib monotherapy or in combination with topical therapy for moderate-to-severe atopic dermatitis (AD) has been demonstrated; however, the long-term stability of responses with continuous abrocitinib monotherapy versus with addition of topical therapy has not been characterized.
Details
- Language :
- English
- ISSN :
- 10811206
- Volume :
- 133
- Issue :
- 6, Number 6 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Annals of Allergy, Asthma & Immunology
- Publication Type :
- Periodical
- Accession number :
- ejs67827420
- Full Text :
- https://doi.org/10.1016/j.anai.2024.08.321